Sweiz Pharmaceutical Private Limited
About Sweiz Pharmaceutical Private Limited
Data last updated:
Sweiz Pharmaceutical Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24233MP2013PTC030303. Its GSTIN is 23AASCS9016P1ZL (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Renuka Bharadwaj and Paresh Kumar Vishwakarma.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Mahendra Business Square Bawadiya Kalan Huzur, Bhopal, Madhya Pradesh, India – 462026.
As per the financials filed for FY 2023, the company reported a revenue of ₹11.71 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net loss of ₹6.71 Lakh (net margin -57.3%) and EBITDA of -₹6.58 Lakh (EBITDA margin -56.2%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sweiz Pharmaceutical Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressMahendra Business Square Bawadiya Kalan Huzur, Bhopal, Madhya Pradesh, India – 462026
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sweiz Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sweiz Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sweiz Pharmaceutical Private Limited, buy the company report.
Financials of Sweiz Pharmaceutical Private Limited
FY 2023 filings availableSweiz Pharmaceutical Private Limited reported revenue of ₹11.71 Lakh (down 16% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 16% fall in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -56.2% | ||||
| Net Profit Margin | -57.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sweiz Pharmaceutical Private Limited, buy the company report.
Board of directors of Sweiz Pharmaceutical Private Limited
Sweiz Pharmaceutical has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renuka Bharadwaj | Director | 01 Mar 2015 | 11 Years 7 Months | Current |
| Paresh Kumar Vishwakarma | Director | 13 May 2019 | 7 Years 5 Months | Current |
| Karan Tanwani | Additional Director | 01 Sep 2016 | 10 Years 1 Months | Current |
| Rajesh Bharadwaj | Additional Director | 18 Mar 2013 | 13 Years 7 Months | Current |
Auditor
Sweiz Pharmaceutical Private Limited is audited by PRIYA KAUSHIK & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRIYA KAUSHIK & CO | FY 2019 | 009322C |
Shareholding
The shareholding of Sweiz Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sweiz Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jun 2020 | 100356671 | Idbi Bank Limited | ₹1 Lakh | Open | |
| 23 Dec 2019 | 100317698 | Idbi Bank Limited | ₹6 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Sweiz Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sweiz Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sweiz Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AASCS9016P1ZL | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sweiz Pharmaceutical Private Limited, buy the company report.
Recent activity
Sweiz Pharmaceutical Private Limited has 5 board changes on record since 2013: 4 appointments and 1 cessation. The latest: Paresh Kumar Vishwakarma was appointed as Director on 13 May 2019.
Frequently asked questions
Sweiz Pharmaceutical is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 March 2013 (13+ years old) and is registered under CIN U24233MP2013PTC030303.
Sweiz Pharmaceutical has 4 current directors:
- Renuka Bharadwaj - Director
- Paresh Kumar Vishwakarma - Director
- Karan Tanwani - Additional Director
- Rajesh Bharadwaj - Additional Director
The latest financial statements of Sweiz Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Sweiz Pharmaceutical is 23AASCS9016P1ZL, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Sweiz Pharmaceutical is U24233MP2013PTC030303. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sweiz Pharmaceutical was incorporated on 18 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Gwalior.
Paresh Kumar Vishwakarma was appointed as Director on 13 May 2019. Karan Tanwani was appointed as Additional Director on 01 Sep 2016. Renuka Bharadwaj was appointed as Director on 01 Mar 2015. Sweiz Pharmaceutical has 5 board changes on record in total.
The registered office of Sweiz Pharmaceutical is at Mahendra Business Square Bawadiya Kalan Huzur, Bhopal, Madhya Pradesh, India – 462026.
Sweiz Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sweiz Pharmaceutical has open charges of ₹7 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
